PFE vs PLTR: Which Is the Better Buy?
Side-by-side comparison of Pfizer Inc. and Palantir Technologies Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-07.
Pfizer Inc. · Healthcare
$26.33
+28.6% upside to fair value
Grade B
VS
Palantir Technologies Inc. · Technology
$133.79
-41.7% upside to fair value
Grade C
High Quality
QuantHub Verdict
PFE has more upside to fair value
(+28.6%).
PFE trades at a lower forward P/E
(19.3x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
PFE |
PLTR |
| Current Price |
$26.33 |
$133.79 |
| Fair Value Estimate |
$33.85 |
$78.04 |
| Upside to Fair Value |
+28.6%
|
-41.7%
|
| Market Cap |
$149.8B |
$306.6B |
| Forward P/E |
19.3x
|
140.4x
|
| EV / EBITDA |
12.9x
|
151.4x
|
| Price / Sales |
2.4x
|
58.7x
|
| Price / FCF |
16.5x
|
114.0x
|
| Revenue Growth YoY |
-1.2%
|
+84.7%
|
| Gross Margin |
70.3%
|
84.1%
|
| Operating Margin |
24.7%
|
38.1%
|
| Return on Equity |
8.7%
|
32.2%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
6.06%
|
0.88%
|
| Analyst Consensus |
Hold
|
Buy
|
Investment Thesis
Pfizer Inc. is a leading global pharmaceutical company specializing in drug manufacturing with a strong presence in vaccines, oncology, and primary care. The company benefits from a seasoned leadership team under CEO Albert Bourla, who has driven a strategic transformation focusing on science-driven innovation and portfolio optimization. Despite a high gross margin of 70.3% and solid operating ma…
Palantir Technologies Inc. is a high-growth enterprise software company specializing in data analytics and intelligence platforms for government and commercial clients. The company benefits from a durable competitive moat through its established government contracts, proprietary platforms Gotham and Foundry, and expanding commercial footprint. Palantir's revenue grew 84.7% year-over-year in the m…
Accumulation Zones
| Metric |
PFE |
PLTR |
| Zone Low |
$25.39 |
$58.53 |
| Zone High |
$28.77 |
$66.33 |
| In Buy Zone? |
Yes
|
No
|